NorthPalm Capital

NorthPalm Capital is a private investment firm and family office headquartered in Palm Beach Gardens, Florida, with a primary focus on the life sciences and biotechnology sectors. The firm serves as the strategic investment vehicle for Dr. Neil Desai, a prominent biopharmaceutical executive known for founding Aadi Bioscience and inventing the nanoparticle albumin-bound (nab) technology used in Abraxane. NorthPalm Capital provides capital and strategic guidance to healthcare companies, maintaining significant equity positions in enterprises focused on oncology and innovative drug delivery platforms. The firm leverages its leadership's extensive experience in drug development and commercialization to support high-impact medical innovations. It is notably a major shareholder in Aadi Bioscience, reflecting its commitment to advancing precision oncology therapies.